CN1299673C - 盐酸氨溴索滴丸及其制备方法 - Google Patents
盐酸氨溴索滴丸及其制备方法 Download PDFInfo
- Publication number
- CN1299673C CN1299673C CNB2004100648218A CN200410064821A CN1299673C CN 1299673 C CN1299673 C CN 1299673C CN B2004100648218 A CNB2004100648218 A CN B2004100648218A CN 200410064821 A CN200410064821 A CN 200410064821A CN 1299673 C CN1299673 C CN 1299673C
- Authority
- CN
- China
- Prior art keywords
- ambroxol hydrochloride
- present
- fine powder
- preparation
- coolant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- QNVKOSLOVOTXKF-UHFFFAOYSA-N 4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol;hydron;chloride Chemical compound Cl.NC1=C(Br)C=C(Br)C=C1CNC1CCC(O)CC1 QNVKOSLOVOTXKF-UHFFFAOYSA-N 0.000 title claims abstract description 38
- 229960000985 ambroxol hydrochloride Drugs 0.000 title claims abstract description 38
- 239000006187 pill Substances 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 5
- 239000000758 substrate Substances 0.000 claims description 11
- 230000004927 fusion Effects 0.000 claims description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 claims description 6
- -1 polyoxyethylene Polymers 0.000 claims description 5
- 239000004094 surface-active agent Substances 0.000 claims description 5
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 claims description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 4
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 4
- 235000021355 Stearic acid Nutrition 0.000 claims description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 4
- 229940055577 oleyl alcohol Drugs 0.000 claims description 4
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 claims description 4
- 229940093429 polyethylene glycol 6000 Drugs 0.000 claims description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 4
- 239000008117 stearic acid Substances 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 125000005456 glyceride group Chemical group 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 235000011185 polyoxyethylene (40) stearate Nutrition 0.000 claims description 3
- 239000001194 polyoxyethylene (40) stearate Substances 0.000 claims description 3
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 claims description 3
- IQXJCCZJOIKIAD-UHFFFAOYSA-N 1-(2-methoxyethoxy)hexadecane Chemical compound CCCCCCCCCCCCCCCCOCCOC IQXJCCZJOIKIAD-UHFFFAOYSA-N 0.000 claims description 2
- 239000001828 Gelatine Substances 0.000 claims description 2
- 229950009789 cetomacrogol 1000 Drugs 0.000 claims description 2
- 229920000159 gelatin Polymers 0.000 claims description 2
- 235000019322 gelatine Nutrition 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 229940093430 polyethylene glycol 1500 Drugs 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 abstract description 22
- 239000002826 coolant Substances 0.000 abstract description 16
- 238000000034 method Methods 0.000 abstract description 7
- 208000019505 Deglutition disease Diseases 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract 3
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 description 8
- 206010036790 Productive cough Diseases 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- 229940008099 dimethicone Drugs 0.000 description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 208000024794 sputum Diseases 0.000 description 5
- 210000003802 sputum Anatomy 0.000 description 5
- 238000012360 testing method Methods 0.000 description 4
- 239000002775 capsule Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000005696 Diammonium phosphate Substances 0.000 description 2
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 2
- 229910000388 diammonium phosphate Inorganic materials 0.000 description 2
- 235000019838 diammonium phosphate Nutrition 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 1
- 208000032571 Infant acute respiratory distress syndrome Diseases 0.000 description 1
- 206010028974 Neonatal respiratory distress syndrome Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 238000011978 dissolution method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000003580 lung surfactant Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000000420 mucociliary effect Effects 0.000 description 1
- 201000002652 newborn respiratory distress syndrome Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Abstract
Description
时间(分钟) | 5 | 10 | 20 | 30 | 45 |
溶出度(%) | 25.8 | 39.4 | 49.1 | 68.7 | 79.3 |
时间(分钟) | 5 | 10 | 20 | 30 | 45 |
溶出度(%) | 80.3 | 92.1 | 99.4 | 99.8 | 99.6 |
时间(分钟) | 5 | 10 | 20 | 30 | 45 |
溶出度(%) | 60.2 | 80.9 | 97.3 | 99.2 | 99.8 |
时间(分钟) | 5 | 10 | 20 | 30 | 45 |
溶出度(%) | 46.8 | 85.2 | 96.4 | 99.5 | 99.9 |
时间(分钟) | 5 | 10 | 20 | 30 | 45 |
溶出度(%) | 31.9 | 65.9 | 98.2 | 99.8 | 99.7 |
时间(分钟) | 5 | 10 | 20 | 30 | 45 |
溶出度(%) | 48.5 | 89.7 | 97.8 | 99.4 | 99.6 |
时间(分钟) | 5 | 10 | 20 | 30 | 45 |
溶出度(%) | 31.2 | 48.2 | 89.5 | 97.2 | 99.4 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100648218A CN1299673C (zh) | 2004-10-01 | 2004-10-01 | 盐酸氨溴索滴丸及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100648218A CN1299673C (zh) | 2004-10-01 | 2004-10-01 | 盐酸氨溴索滴丸及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1634004A CN1634004A (zh) | 2005-07-06 |
CN1299673C true CN1299673C (zh) | 2007-02-14 |
Family
ID=34846425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100648218A Expired - Fee Related CN1299673C (zh) | 2004-10-01 | 2004-10-01 | 盐酸氨溴索滴丸及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1299673C (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004021992A1 (de) * | 2004-05-03 | 2005-11-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Topische Zubereitung enthaltend Ambroxol |
CN106420625B (zh) * | 2015-08-12 | 2021-02-26 | 北京科信必成医药科技发展有限公司 | 一种稳定的盐酸氨溴索掩味颗粒及其制备方法 |
CN110151712A (zh) * | 2019-05-14 | 2019-08-23 | 扬子江药业集团江苏紫龙药业有限公司 | 一种盐酸左氧氟沙星滴丸及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1442148A (zh) * | 2003-03-26 | 2003-09-17 | 耿燕 | 黄豆苷元滴丸及其制备方法 |
CN1528274A (zh) * | 2003-10-08 | 2004-09-15 | 南昌弘益科技有限公司 | 盐酸甲氧那明滴丸及其制备方法 |
CN1602848A (zh) * | 2004-08-23 | 2005-04-06 | 南昌弘益科技有限公司 | 盐酸氨索溴滴丸及其制备方法 |
-
2004
- 2004-10-01 CN CNB2004100648218A patent/CN1299673C/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1442148A (zh) * | 2003-03-26 | 2003-09-17 | 耿燕 | 黄豆苷元滴丸及其制备方法 |
CN1528274A (zh) * | 2003-10-08 | 2004-09-15 | 南昌弘益科技有限公司 | 盐酸甲氧那明滴丸及其制备方法 |
CN1602848A (zh) * | 2004-08-23 | 2005-04-06 | 南昌弘益科技有限公司 | 盐酸氨索溴滴丸及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1634004A (zh) | 2005-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1299673C (zh) | 盐酸氨溴索滴丸及其制备方法 | |
CN1730030A (zh) | 广金钱草滴丸及其制备方法 | |
CN1307979C (zh) | 紫珠止血滴丸及其制备方法 | |
CN1301098C (zh) | 毛冬青滴丸及其制备方法 | |
CN1602848A (zh) | 盐酸氨索溴滴丸及其制备方法 | |
CN1490001A (zh) | 水飞蓟素滴丸及其制备方法 | |
CN1679669A (zh) | 远志滴丸及其制备方法 | |
CN1582908A (zh) | 盐酸曲马多滴丸及其制备方法 | |
CN1528287A (zh) | 石吊兰素滴丸及其制备方法 | |
CN1634490A (zh) | 一种治疗咽喉疾病的六灵滴丸及其制备方法 | |
CN1493290A (zh) | 阿魏酸哌嗪滴丸及其制备方法 | |
CN1634473A (zh) | 杏仁止咳滴丸及其制备方法 | |
CN1602868A (zh) | 富马酸酮替芬滴丸及其制备方法 | |
CN1814053A (zh) | 一种治疗妇女病的抗宫炎滴丸及其制备方法 | |
CN1489995A (zh) | 盐酸阿米替林滴丸及其制备方法 | |
CN1720964A (zh) | 一种以白屈菜为原料的胃痛平滴丸及其制备方法 | |
CN1562001A (zh) | 卡络磺钠滴丸及其制备方法 | |
CN1739632A (zh) | 牛黄消炎滴丸及其制备方法 | |
CN1528298A (zh) | 异卡波肼滴丸及其制备方法 | |
CN1739581A (zh) | 脑心舒滴丸及其制备方法 | |
CN1582944A (zh) | 叶绿素铜钠滴丸及其制备方法 | |
CN1546022A (zh) | 盐酸异可利定滴丸及其制备方法 | |
CN1771956A (zh) | 伊曲康唑滴丸及其制备方法 | |
CN1528296A (zh) | 硝酸毛果芸香碱滴丸及其制备方法 | |
CN1582906A (zh) | 盐酸苯海拉明滴丸及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20090327 Address after: No. 28 North Road, Chengdong street, Zhejiang, Wenling Patentee after: Zhejiang Worldbest Pharmaceutical Co., Ltd. Address before: Room C410, National University Science Park, 699 West Changjiang Road, Anhui, Hefei Patentee before: Geng Yan |
|
ASS | Succession or assignment of patent right |
Owner name: ZHEJIANG PROV WANBANG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: GENG YAN Effective date: 20090327 |
|
C56 | Change in the name or address of the patentee |
Owner name: ZHEJIANG WANBANG PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: ZHEJIANG WORLDBEST PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 317500 east of Zhejiang province Wenling city streets Baizhang Road No. 28 Patentee after: Zhejiang Wanbang Pharmaceutical Co., Ltd. Address before: 317500 east of Zhejiang province Wenling city streets Baizhang Road No. 28 Patentee before: Zhejiang Worldbest Pharmaceutical Co., Ltd. |
|
C56 | Change in the name or address of the patentee |
Owner name: WANBANGDE PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER NAME: ZHEJIANG WANBANG PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 317500 east of Zhejiang province Wenling city streets Baizhang Road No. 28 Patentee after: WANBANGDE PHARMACEUTICAL GROUP CO., LTD. Address before: 317500 east of Zhejiang province Wenling city streets Baizhang Road No. 28 Patentee before: Zhejiang Wanbang Pharmaceutical Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070214 Termination date: 20161001 |
|
CF01 | Termination of patent right due to non-payment of annual fee |